Gene · 1973
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics. | Clin Proteomics | 2023 | 37940875 | PubTator, text mining | PubMed |
| Role of c-Myc in lung cancer: Progress, challenges, and prospects. | Chin Med J Pulm Crit Care Med | 2023 | 37920609 | PubTator, text mining | PubMed |
| Biological function and clinical application prospect of tsRNAs in digestive system biology and pathology. | Cell Commun Signal | 2023 | 37904174 | PubTator, text mining | PubMed |
| Identification of Host Factors Interacting with a γ-Shaped RNA Element from a Plant Virus-Associated Satellite RNA. | Viruses | 2023 | 37896816 | PubTator, text mining | PubMed |
| Current Knowledge on the Interaction of Human Cytomegalovirus Infection, Encoded miRNAs, and Acute Aortic Syndrome. | Viruses | 2023 | 37896804 | PubTator, text mining | PubMed |
| Redox-Mediated Rewiring of Signalling Pathways: The Role of a Cellular Clock in Brain Health and Disease. | Antioxidants (Basel) | 2023 | 37891951 | PubTator, text mining | PubMed |
| Cell-Permeable Stimuli-Responsive Ubiquitin Probe for Time-Resolved Monitoring of Substrate Ubiquitination in Live Cells. | JACS Au | 2023 | 37885572 | PubTator, text mining | PubMed |
| Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. | J Clin Invest | 2023 | 37874652 | PubTator, text mining | PubMed |
| ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity. | Int J Mol Sci | 2023 | 37834383 | PubTator, text mining | PubMed |
| Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status. | Cell Commun Signal | 2023 | 37828578 | PubTator, text mining | PubMed |
| An interaction between eIF4A3 and eIF3g drives the internal initiation of translation. | Nucleic Acids Res | 2023 | 37811880 | PubTator, text mining | PubMed |
| Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia. | Cancer Commun (Lond) | 2023 | 37803910 | PubTator, text mining | PubMed |
| Amino acid transporter SLC38A5 is a tumor promoter and a novel therapeutic target for pancreatic cancer. | Sci Rep | 2023 | 37803043 | PubTator, text mining | PubMed |
| Corrigendum: The human milk proteome and allergy of mother and child: exploring associations with protein abundances and protein network connectivity. | Front Immunol | 2023 | 37795098 | PubTator, text mining | PubMed |
| First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma. | Res Sq | 2023 | 37790486 | PubTator, text mining | PubMed |
| Secondary structures that regulate mRNA translation provide insights for ASO-mediated modulation of cardiac hypertrophy. | Nat Commun | 2023 | 37789015 | PubTator, text mining | PubMed |
| Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37784141 | PubTator, text mining | PubMed |
| A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs. | Sci Rep | 2023 | 37770477 | PubTator, text mining | PubMed |
| The Helix-Loop-Helix motif of human EIF3A regulates translation of proliferative cellular mRNAs. | PLoS One | 2023 | 37768948 | PubTator, text mining | PubMed |
| Increased Expression of lncRNA AC000120.7 and SENP3-EIF4A1 in Patients with Acute Respiratory Distress Syndrome Induced by SARS-CoV-2 Infection: A Pilot Study. | Microorganisms | 2023 | 37764186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1973/papers?page=7